Standout Papers

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up... 2011 2026 2016 2021 432
  1. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) (2011)
    Hagop M. Kantarjian, Neil P. Shah et al. Blood

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 55 standout
Sub-graph 1 of 19

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Natural Hydrogels Support Kidney Organoid Generation and Promote In Vitro Angiogenesis
2024 Standout
44 intermediate papers

Works of Franck E. Nicolini being referenced

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
2018
Immature CML cells implement a BMP autocrine loop to escape TKI treatment
2017
and 14 more

Author Peers

Author Last Decade Papers Cites
Franck E. Nicolini 1430 1187 685 64 1.6k
Verity A Saunders 1217 993 558 61 1.6k
Pascale Cony‐Makhoul 1222 843 496 76 1.5k
Agnès Guerci‐Bresler 1339 1121 536 53 1.4k
Anna Turkina 1088 954 516 120 1.4k
Sandip Shah 1081 860 542 45 1.4k
Phuong Dang 1362 1119 632 30 1.6k
Beatriz Moiraghi 1762 1504 1000 41 2.0k
Chao Zhu 1788 1496 1009 48 2.2k
Agnès Guerci 1885 1314 655 49 2.0k
Valentín García‐Gutiérrez 1594 1357 756 105 2.0k

All Works

Loading papers...

Rankless by CCL
2026